ABVC earnings: a positive outcome, +7.2%

On November 15, 2021, ABVC BIOPHARMA, INC. reached its earnings. The result was a positive outcome, and the stock moved +7.2% in the window around the event. It had already run +22.5% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.